Splash
Splash

Past Events

Past Events

November 17 2020 10:50 AM EST15:50 GMT
Jefferies London Virtual Healthcare Conference
November 16 2020 04:00 PM EST21:00 GMT
Stifel 2020 Virtual Healthcare Conference
October 29 2020 09:00 AM EDT13:00 GMT
Verona Pharma Third Quarter 2020 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 2469127:

  • +1-888-317-6003 for callers in the United States
  • +1-412-317-6061 for international callers
September 21 2020 03:45 PM EDT20:45 BST
Verona Pharma to Ring the Nasdaq Closing Bell
September 14 2020 05:00 PM EDT22:00 BST
H.C. Wainwright 22nd Annual Global Investment Virtual Conference
August 14 2020 09:00 AM EDT14:00 BST
Verona Pharma Second Quarter 2020 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 4180419:

877-870-9135 for callers in the United States
+44 800 279 6619 for international callers

August 13 2020 04:30 PM EDT21:30 BST
Canaccord Genuity 40th Annual Growth Conference
August 12 2020 11:30 AM EDT16:30 BST
2020 Wedbush PacGrow Healthcare Virtual Conference
August 10 2020 02:30 PM EDT19:30 BST
BTIG Virtual Biotechnology Conference 2020
June 1 2020 07:30 AM EDT12:30 BST
Investor and Analyst KOL Webcast

To participate, please dial one of the following numbers and reference conference ID 6954635:

877-870-9135 for callers in the United States
0207 192 8338 for callers in the United Kingdom
0800 723 4756 for callers in Germany

April 30 2020 09:00 AM EDT14:00 BST
Verona Pharma First Quarter 2020 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 2667888:

866-940-4574 for callers in the United States
0800 028 8438 for callers in the United Kingdom
0800 181 5287 for callers in Germany

April 16 2020 05:30 AM EDT10:30 BST
Annual General Meeting 2020
February 27 2020 09:00 AM EST14:00 GMT
Verona Pharma Full Year 2019 Financial Results and Conference Call

Conference call time: 9.00 am EST / 2.00 pm GMT.

To participate, please dial one of the following numbers and reference conference ID 5394158:

  • 866-940-4574 for callers in the United States
  • 0800 028 8438 for callers in the United Kingdom
  • 0800 181 5287 for callers in Germany
February 4 2020 08:45 AM EST13:45 GMT
LSX World Congress 2020
January 13 2020 09:00 AM EST14:00 GMT
Verona Pharma to Report 4 Week Phase 2b COPD Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
November 20 2019 12:20 PM EST17:20 GMT
Jefferies 2019 London Healthcare Conference
November 19 2019 08:00 AM EST13:00 GMT
Stifel 2019 Healthcare Conference
Presenter: Jan-Anders Karlsson, CEO
November 18 2019 12:00 AM EST05:00 GMT
Guggenheim Healthcare Talks Idea Forum | Neuro/Immunology Day
November 5 2019 08:00 AM EST13:00 GMT
Verona Pharma Third Quarter 2019 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 6498479:

866-940-4574 for callers in the United States
0800 028 8438 for callers in the United Kingdom
0800 181 5287 for callers in Germany

September 10 2019 03:00 PM EDT20:00 BST
2019 H.C. Wainwright 21st Annual Global Investment Conference
August 13 2019 01:55 PM EDT18:55 BST
2019 Wedbush PacGrow Healthcare Conference

Supporting materials

Wedbush Presentation

August 12 2019 12:00 AM EDT05:00 BST
BTIG Biotechnology Conference 2019
August 6 2019 08:00 AM EDT13:00 BST
Verona Pharma Second Quarter 2019 Financial Results and Conference Call
August 5 2019 08:00 AM EDT13:00 BST
Ensifentrine (RPL554) Positive Data from 7-Day Phase 2 Clinical Trial in COPD Patients with Dry Powder Inhaler Formulation
June 5 2019 08:30 AM EDT13:30 BST
Jefferies 2019 Global Healthcare Conference

Jan-Anders Karlsson, Chief Executive Officer and Executive Director

May 20 2019 12:00 AM EDT05:00 BST
Expanded Analysis of Clinical Data at ATS 2019
May 8 2019 12:00 AM EDT05:00 BST
Investor & Analyst R&D Forum London 2019
May 7 2019 08:00 AM EDT13:00 BST
Verona Pharma First Quarter 2019 Financial Results and Conference Call
May 7 2019 05:00 AM EDT10:00 BST
Annual General Meeting of Shareholders
Click here for more information
April 8 2019 12:30 PM EDT17:30 BST
H.C Wainwright Global Life Sciences Conference
March 13 2019 10:00 AM EDT14:00 GMT
Cowen and Company 39th Annual Health Care Conference

Supporting materials

Cowen presentation

March 12 2019 09:00 AM EDT13:00 GMT
Verona Pharma presents at Ligand Pharmaceuticals Analyst Day

Supporting materials

Ligand presentation

February 26 2019 08:00 AM EST13:00 GMT
Verona Pharma Full Year 2018 Financial Results and Conference Call
January 14 2019 08:00 AM EST13:00 GMT
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
January 7 2019 06:23 PM EST23:23 GMT
JP Morgan Conference

Supporting materials

JP Morgan Conference

December 21 2018 12:35 PM EST17:35 GMT
Citi Healthcare Conference
November 13 2018 08:45 AM EST13:45 GMT
Verona Pharma to Present at Stifel 2018 Healthcare Conference
November 6 2018 08:00 AM EST13:00 GMT
Verona Pharma Third Quarter 2018 Financial Results and Conference Call
October 12 2018 11:00 AM EDT16:00 BST
Investor & Analyst R&D Forum
September 18 2018 08:00 AM EDT13:00 BST
Verona Pharma Presents Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress
Splash

© Verona Pharma plc 2020. All rights reserved